Terumo Says Nobori Heart Stent Equal To Abbott's Xience In Japan Study
This article was originally published in PharmAsia News
Executive Summary
Terumo said a comparative study with the Xience heart stent of Abbott Laboratories showed the Japan device maker's was equal in efficacy for the drug-coated devices in preventing the need for a second artery-clearing procedure.